3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.

Congenital or hereditary myasthenia describes a heterogeneous group of disorders in which the immune system is not implicated. Treatment has previously depended on anticholinesterase medication. The effectiveness of 3,4-diaminopyridine (3,4-DAP), a preparation that enhances acetylcholine release fro...

Bibliográfalaš dieđut
Váldodahkkit:	Palace, J, Wiles, C, Newsom-Davis, J
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	1991

Geahča maid

Congenital myasthenia - Rapsyn deficiency: How rare?
Dahkki: Burke, G, et al.
Almmustuhtton: (2003)

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.
Dahkki: Burke, G, et al.
Almmustuhtton: (2003)

The therapeutic efficacy of post-symptom 3,4-diaminopyridine treatment in cosmetic injection-induced botulism using a novel animal model
Dahkki: Ping He, et al.
Almmustuhtton: (2024-09-01)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
Dahkki: Palace, J, et al.
Almmustuhtton: (1998)

Congenital myasthenia: contrasting rapsyn and Dok-7 phenotypes
Dahkki: Palace, J
Almmustuhtton: (2010)

Failure of 3,4-diaminopyridine and edrophonium to produce significant clinical benefit in neurotoxicity following the bite of Papuan taipan (Oxyuranus scutellatus canni).
Dahkki: Trevett, A, et al.
Almmustuhtton: (1995)

Hereditary and Autoimmune Myasthenias
Dahkki: Beeson, D
Almmustuhtton: (2013)

FAST CHANNEL CONGENITAL MYASTHENIA: REVIEW OF 12 CASES AND TREATMENT CHALLENGES
Dahkki: Finlayson, S, et al.
Almmustuhtton: (2012)

EPHEDRINE TREATMENT RESULTS IN PROFOUND FUNCTIONAL IMPROVEMENTS IN DOK-7 CONGENITAL MYASTHENIA
Dahkki: Lashley, D, et al.
Almmustuhtton: (2009)

Memory in myasthenia gravis: neuropsychological tests of central cholinergic function before and after effective immunologic treatment.
Dahkki: Glennerster, A, et al.
Almmustuhtton: (1996)

Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
Dahkki: Croxen, R, et al.
Almmustuhtton: (2002)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis
Dahkki: Palace, J, et al.
Almmustuhtton: (1998)

"THE EYES HAVE IT": INITIAL GENETIC SCREENING IN SUSPECTED CONGENITAL MYASTHENIA
Dahkki: Lashley, D, et al.
Almmustuhtton: (2010)

A nationwide service for the diagnosis and treatment of congenital myasthenic syndromes
Dahkki: Burke, G, et al.
Almmustuhtton: (2006)

Recurrent congenital arthrogryposis leading to a diagnosis of myasthenia gravis in an initially asymptomatic mother.
Dahkki: Barnes, P, et al.
Almmustuhtton: (1995)

Seronegative myasthenia gravis.
Dahkki: Vincent, A, et al.
Almmustuhtton: (2004)

Congenital fibre type disproportion associated with mutations in the tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.
Dahkki: Munot, P, et al.
Almmustuhtton: (2010)

Congenital Myasthenia and Facial Malformations
Dahkki: J Gordon Millichap
Almmustuhtton: (1990-12-01)

CHRNE Mutation and Congenital Myasthenia
Dahkki: J Gordon Millichap
Almmustuhtton: (2009-01-01)

Congenital Arthrogryposis and Maternal Myasthenia
Dahkki: J Gordon Millichap
Almmustuhtton: (1988-02-01)

Congenital and Juvenile Myasthenia Gravis
Dahkki: J Gordon Millichap
Almmustuhtton: (1996-08-01)

A New Proton Transfer Complex Between 3,4-Diaminopyridine Drug and 2,6-Dichloro-4-nitrophenol: Synthesis, Spectroscopic Characterization, DFT Studies, DNA Binding Analysis, and Antitumor Activity
Dahkki: Reem M. Alghanmi, et al.
Almmustuhtton: (2024-10-01)

Clinical features in a series of fast channel congenital myasthenia syndrome.
Dahkki: Palace, J, et al.
Almmustuhtton: (2012)

Clinical features in a series of fast channel congenital myasthenia syndrome.
Dahkki: Palace, J, et al.
Almmustuhtton: (2012)

Ternary Complexation Process for New Spectrophotometric Assay of Levodopa using Ni(II) and 2,3-Diaminopyridine
Dahkki: Fadam Abdoon, et al.
Almmustuhtton: (2022-01-01)

Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
Dahkki: Buckley, C, et al.
Almmustuhtton: (2001)

Myasthenia gravis.
Dahkki: Vincent, A, et al.
Almmustuhtton: (2001)

The management of myasthenia gravis
Dahkki: Hilton-Jones, D, et al.
Almmustuhtton: (2005)

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
Dahkki: Vincent, A, et al.
Almmustuhtton: (2003)

How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia.
Dahkki: Parr, JR, et al.
Almmustuhtton: (2014)

Clinical aspects of myasthenia explained.
Dahkki: Verschuuren, J, et al.
Almmustuhtton: (2010)

Retracted: Ternary Complexation Process for New Spectrophotometric Assay of Levodopa using Ni(II) and 2,3-Diaminopyridine
Dahkki: Advances in Materials Science and Engineering
Almmustuhtton: (2023-01-01)

Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
Dahkki: Jitpimolmard, S, et al.
Almmustuhtton: (2006)

Updates on congenital hereditary endothelial dystrophy
Dahkki: Neet Mehta, et al.
Almmustuhtton: (2023-01-01)

Myasthenia gravis: diagnostic and management dilemmas.
Dahkki: Palace, J, et al.
Almmustuhtton: (2001)

The genetic diagnosis of congenital myasthenic syndromes (CMS)
Dahkki: Man, S, et al.
Almmustuhtton: (2005)

Myasthenia gravis and Lambert-Eaton myasthenic syndrome
Dahkki: Palace, J, et al.
Almmustuhtton: (2004)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
Dahkki: Mygland, A, et al.
Almmustuhtton: (2000)

Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
Dahkki: Farrugia, M, et al.
Almmustuhtton: (2007)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
Dahkki: McConville, J, et al.
Almmustuhtton: (2002)